Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,348Revenue $M172Net Margin (%)9.3Z-Score26.5
Enterprise Value $M1,243EPS $0.6Operating Margin %14.6F-Score4
P/E(ttm))79.1Cash Flow Per Share $0.9Pre-tax Margin (%)14.5Higher ROA y-yN
Price/Book6.710-y EBITDA Growth Rate %13.3Quick Ratio5.5Cash flow > EarningsY
Price/Sales7.35-y EBITDA Growth Rate %8.2Current Ratio6.5Lower Leverage y-yY
Price/Cash Flow43.2y-y EBITDA Growth Rate %2.7ROA % (ttm)7.8Higher Current Ratio y-yN
Dividend Yield %0.5Insider Buy (3m)0ROE % (ttm)8.9Less Shares Outstanding y-yN
Payout Ratio %26.0Shares Outstanding M22.5ROI % (ttm)16.1Gross Margin Increase y-yN

Gurus Latest Trades with ABAX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABAXJoel Greenblatt 2014-09-30 Reduce-0.01%$41.8 - $53.11
($47)
$ 59.8127%Reduce -39.12%16,012
ABAXJoel Greenblatt 2014-06-30 Add$37.95 - $44.61
($41.57)
$ 59.8144%Add 30.03%26,303
ABAXPRIMECAP Management 2014-03-31 Add0.06%$36.29 - $45.01
($39.69)
$ 59.8151%Add 244.23%1,979,300
ABAXJoel Greenblatt 2014-03-31 Reduce-0.01%$36.29 - $45.01
($39.69)
$ 59.8151%Reduce -21.35%20,229
ABAXPRIMECAP Management 2013-12-31 Buy 0.03%$32.4 - $41.25
($36.8)
$ 59.8162%New holding, 575000 sh.575,000
ABAXJoel Greenblatt 2013-12-31 Buy 0.02%$32.4 - $41.25
($36.8)
$ 59.8162%New holding, 25721 sh.25,721
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABAX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABAX PRIMECAP Management 2014-09-301,973,2008.750.11-0.13%
ABAX Joel Greenblatt 2014-09-3016,0120.070.01-39.12%
Premium Most recent portfolio changes are included for Premium Members only!


ABAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ARON KENNETHChief Technology Officer 2014-12-08Sell2,000$56.685.52view
SEVERSON CLINTONPresident,CEO & Board Chairman 2014-11-25Sell2,286$566.8view
SEVERSON CLINTONPresident,CEO & Board Chairman 2014-11-13Sell10,000$558.75view
SEVERSON CLINTONPresident,CEO & Board Chairman 2014-11-05Sell10,000$5410.76view
INES ALBERTO SANTACFO and VP of Finance 2014-11-03Sell1,652$53.0912.66view
SEVERSON CLINTONPresident,CEO & Board Chairman 2014-11-03Sell5,000$5312.85view
INES ALBERTO SANTACFO and VP of Finance 2014-11-03Sell10,621$52.9512.96view
SEVERSON CLINTONPresident,CEO & Board Chairman 2014-10-31Sell10,000$51.516.14view
BASTIANI RICHARDDirector 2014-08-12Sell1,000$45.431.74view
INES ALBERTO SANTACFO and VP of Finance 2014-07-30Sell10,738$47.8125.1view

Press Releases about ABAX :

    Quarterly/Annual Reports about ABAX:

    News about ABAX:

    Articles On GuruFocus.com
    ABAXIS Inc. (ABAX) COO Donald Peter Wood sells 6,460 Shares Mar 08 2011 
    ABAXIS Inc. (ABAX) President,CEO & Board Chairman Clinton Severson sells 35,000 Shares Dec 10 2010 
    ABAXIS Inc. (ABAX) President,CEO & Board Chairman Clinton Severson sells 96,000 Shares Dec 08 2010 
    ABAXIS Inc. (ABAX) President,CEO & Board Chairman Clinton Severson sells 66,029 Shares Dec 07 2010 
    ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd. Jan 13 2009 


    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK